PUBLIC CONTRACT · 2018
Atezolizumab 60 mg/ml sol inj fr 20 ml IV
- Contract value
- €45,733.16
- Signed on
- 11 July 2018
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5771535PUBLISHED DESCRIPTION
040122762018 ATEZOLIZUMAB 60MG/ML SOL. INJ. FRS 20ML IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €45,733.16
- Procedure base price
- €0.00
- Total effective price
- €45,733.16
- Publication date
- 12 August 2019
- Award date
- 11 July 2018
- Signing date
- 11 July 2018
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33698000-9 - Produtos para fins clínicos
- Legal basis
- Artigo 20.º, n.º 1, alínea d) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3727545
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.